As we build up to Childhood Cancer Awareness Month in September, we are busy finalising arrangements for our second international childhood cancer research symposium.

Taking place on the 11 and 12 September in Manchester, we are bringing together a focused group of 50 clinicians and scientists to discuss how we can make molecular radiotherapy work better for children with neuroblastoma.

With 22 presentations and open discussion over the two-day event, we’re confident that this international childhood cancer research symposium will spark new collaborations and inspire new research ideas which could go on to be the difference for children diagnosed with neuroblastoma in the future.

Our special thanks go to Dr Mark Gaze who has played an instrumental role in hosting this event and pulling together a lively agenda, along with the support of our Scientific Advisory Board.

Events like this where clinicians, who are treating children with cancer every day, and specialist scientists, who are researching potential advances in neuroblastoma treatment, can come together to collaborate and share ideas are truly unique. Collaboration is key in helping ensure that children with cancer can survive and thrive and through this event we will openly share ideas, research, and data both nationally and internationally.

We will report back following the event to share some of the discussion and outcomes. In the meantime, thanks go to our event sponsors, AstraZeneca, Recordati, and Siemens Healthineers, who have all contributed to make this unique research event a reality. We are also delighted to be joined on the day by Neuroblastoma UK and Solving Kids Cancer so that we can share the discussions with other specialist charities for the benefit of all.